Common Contracts
17 similar Underwriting Agreement contracts by Crown Castle International Corp, Biohaven Pharmaceutical Holding Co Ltd., Conseco Inc, others
3,775,000 Shares SI-BONE, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • May 8th, 2023 • SI-BONE, Inc. • Surgical & medical instruments & apparatus • New York
SI-BONE, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule II hereto (the “Underwriters”), for which BofA Securities, Inc., Morgan Stanley & Co. LLC and Jefferies LLC are acting as representatives (the “Representatives” or “you”), and the shareholder of the Company (the “Selling Shareholder”) named in Schedule I hereto proposes to sell to the several Underwriters, an aggregate of 3,775,000 shares of its common stock, par value $.0001 per share (the “Firm Shares”), of which 3,502,247 shares are to be issued and sold by the Company and 272,753 shares are to be sold by the Selling Shareholder.
2,686,409 Shares BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. COMMON SHARES, WITHOUT PAR VALUE UNDERWRITING AGREEMENTUnderwriting Agreement • March 17th, 2021 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • New York
3,190,053 Shares SI-BONE, INC. COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENT October 14, 2020Underwriting Agreement • October 16th, 2020 • SI-BONE, Inc. • Surgical & medical instruments & apparatus • New York
This letter is being delivered to you in connection with the offering by SI-BONE, Inc. (the “Company”) of _____ shares of common stock, par value $0.0001 per share (the “Common Stock”), of the Company and the lock-up letter dated ____, 20__ (the “Lock-up Letter”), executed by you in connection with such offering, and your request for a [waiver] [release] dated ____, 20__, with respect to ____ shares of Common Stock (the “Shares”).
UNDERWRITING AGREEMENTUnderwriting Agreement • January 30th, 2020 • Biohaven Pharmaceutical Holding Co Ltd. • Pharmaceutical preparations • New York
8,500,000 Shares NOODLES & COMPANY CLASS A COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT July 26, 2018Underwriting Agreement • July 30th, 2018 • Mill Road Capital II, L.P. • Retail-eating places • New York
Noodles & Company, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”) an aggregate of 2,500,000 shares of the Class A common stock, par value $0.01 per share of the Company (the “Primary Firm Shares”). Certain stockholders (the “Selling Stockholders”) of the Company, named in Schedule III hereto, severally and not jointly, propose to sell to the several Underwriters an aggregate of 6,000,000 shares of the Class A common stock, par value $0.01 per share, of the Company (the “Secondary Firm Shares,” and, together with the Primary Firm Shares, the “Firm Shares”), with each Selling Stockholder selling the amount set forth opposite such Selling Stockholder’s name in Schedule III hereto. The shares of Class A common stock, par value $0.01 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby
26,315,000 Shares SS&C TECHNOLOGIES HOLDINGS, INC. COMMON STOCK ($0.01 PAR VALUE PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • April 6th, 2018 • SS&C Technologies Holdings Inc • Services-prepackaged software • New York
SS&C Technologies Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I to this Agreement (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 26,315,000 shares of the common stock ($0.01 par value per share) of the Company (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters an additional 3,947,250 shares of its common stock ($0.01 par value per share) (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase the Additional Shares granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock ($0.01 par value per share) of the Company to be outstanding after giving effect to the sales contemplated hereby a
MACROGENICS, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • April 2nd, 2018 • Macrogenics Inc • Pharmaceutical preparations • New York
7,765,000 Shares CROWN CASTLE INTERNATIONAL CORP. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT February 28, 2018Underwriting Agreement • March 5th, 2018 • Crown Castle International Corp • Real estate investment trusts • New York
Crown Castle International Corp., a Delaware corporation (the “Company”), proposes to issue and sell to you, the several underwriters named in Schedule I hereto (the “Underwriters”), 7,765,000 shares of its common stock, par value $0.01 per share (the “Shares”). The shares of common stock, par value $0.01 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
60,500,000 Shares VICI PROPERTIES INC. (A Maryland corporation) COMMON STOCK ($0.01 PAR VALUE PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2018 • Vici Properties Inc. • Real estate investment trusts • New York
4,750,000 Shares CROWN CASTLE INTERNATIONAL CORP. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT April 25, 2017Underwriting Agreement • May 1st, 2017 • Crown Castle International Corp • Real estate investment trusts • New York
Crown Castle International Corp., a Delaware corporation (the “Company”), proposes to issue and sell to you, the several underwriters named in Schedule I hereto (the “Underwriters”), 4,750,000 shares of its common stock, par value $0.01 per share (the “Shares”). The shares of common stock, par value $0.01 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
11,350,000 Shares CROWN CASTLE INTERNATIONAL CORP. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENT November 1, 2016Underwriting Agreement • November 7th, 2016 • Crown Castle International Corp • Real estate investment trusts • New York
Crown Castle International Corp., a Delaware corporation (the “Company”), proposes to issue and sell to you, the several underwriters named in Schedule I hereto (the “Underwriters”), 11,350,000 shares of its common stock, par value $0.01 per share (the “Shares”). The shares of common stock, par value $0.01 per share, of the Company to be outstanding after giving effect to the sales contemplated hereby are hereinafter referred to as the “Common Stock.”
10,500,000 Shares SS&C TECHNOLOGIES HOLDINGS, INC. COMMON STOCK ($0.01 PAR VALUE PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • June 24th, 2015 • SS&C Technologies Holdings Inc • Services-prepackaged software • New York
SS&C Technologies Holdings, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I to this Agreement (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 10,500,000 shares of the common stock ($0.01 par value per share) of the Company (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters an additional 1,575,000 shares of its common stock ($0.01 par value per share) (the “Additional Shares”), if and to the extent that the Representatives shall have determined to exercise, on behalf of the Underwriters, the right to purchase the Additional Shares granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The shares of common stock ($0.01 par value per share) of the Company to be outstanding after giving effect to the sales contemplated hereby a
] Shares NORDIC AMERICAN OFFSHORE LTD. COMMON SHARES, $0.01 PAR VALUE PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • June 10th, 2014 • Nordic American Offshore Ltd. • Deep sea foreign transportation of freight • New York
Nordic American Offshore Ltd., a corporation organized and existing under the laws of the Republic of the Marshall Islands (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) [ ] common shares, par value $0.01 per share (the “Firm Shares”). The Company also proposes to issue and sell to the several Underwriters, solely for the purpose of covering over-allotments made in connection with the offering of the Firm Shares, not more than an additional [ ] common shares, par value $0.01 per share (the “Additional Shares”), if and to the extent that you, as Representatives of the several Underwriters, shall have determined to exercise, on behalf of the Underwriters, the right to purchase such common shares granted to the Underwriters in Section 2 hereof. The Firm Shares and the Additional Shares are hereinafter collectively referred to as the “Shares.” The common shares, par value $0.01 per share, of the Company to be outstand
] Shares REGULUS THERAPEUTICS INC. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • August 17th, 2012 • Regulus Therapeutics Inc. • Pharmaceutical preparations • New York
INTRODUCTION. Regulus Therapeutics Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [ ] shares (the “Firm Shares”) of the common stock, $0.001 par value per share (the “Common Stock”), of the Company.
45,000,000 Shares CONSECO, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2010 • Conseco Inc • Accident & health insurance • New York
Conseco, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”), an aggregate of 45,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Firm Shares”).
Shares CONSECO, INC. COMMON STOCK, PAR VALUE $0.01 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • December 14th, 2009 • Conseco Inc • Accident & health insurance • New York
Morgan Stanley & Co. Incorporated As Representative of the Several Underwriters listed in Schedule I hereto c/o Morgan Stanley & Co. Incorporated 1585 Broadway New York, New York 10036
3,000,000 Shares HANSEN MEDICAL, INC. COMMON STOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT April 1, 2008Underwriting Agreement • April 7th, 2008 • Hansen Medical Inc • Orthopedic, prosthetic & surgical appliances & supplies • New York
